OverviewSuggest Edit

IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company's technological expertise and scientific know how.
TypePublic
Founded2000
HQÉvry, FR
Websiteintegragen.com

Latest Updates

Employees (est.) (Feb 2020)42(+8%)
Share Price (Aug 2020)€2.2
Cybersecurity ratingCMore

Key People/Management at IntegraGen

Bernard Courtieu

Bernard Courtieu

Chairman and Chief Executive Officer
Laurence Riot Lamotte

Laurence Riot Lamotte

Chief Financial Officer
Bérengère Génin

Bérengère Génin

Director of Bioinformatics
Catherine David

Catherine David

Quality Director
Emmanuel Martin

Emmanuel Martin

Sales and Marketing Director, IntegraGen Genomics
Show more

IntegraGen Office Locations

IntegraGen has offices in Évry and Cambridge
Évry, FR (HQ)
5 Rue Henri Auguste Desbruères
Cambridge, US
1 Mifflin Pl #400
Show all (2)

IntegraGen Financials and Metrics

IntegraGen Revenue

Market capitalization (6-Aug-2020)

14.4m

Closing stock price (6-Aug-2020)

2.2
IntegraGen's current market capitalization is €14.4 m.
Show all financial metrics

IntegraGen Cybersecurity Score

Cybersecurity ratingPremium dataset

C

70/100

SecurityScorecard logo

IntegraGen Online and Social Media Presence

Embed Graph

IntegraGen Blogs

IntegraGen announces leading U.S. cancer center to use MERCURY™ cloud-based tool for oncology sequencing data interpretation and reporting

IntegraGen today announced Dana-Farber Cancer Institute will utilize the company’s MERCURY™ cloud-based software as part of their analysis and reporting process for sequencing data obtained from tumors of cancer patients. Dana-Farber plans to utilize MERCURY to assist in the analysis of sequencing d…

COVID-19 update: IntegraGen remains committed to meeting our customers needs

Dear IntegraGen partner and customer, We value your well-being and understand that the entire community is impacted by the novel coronavirus (COVID-19) outbreak. This is why we are committed to providing consistent and timely support so your important work is not interrupted. IntegraGen is closely m…

IntegraGen renews its agreement with the Institut Pasteur related to high-throughput sequencing for microbiology

IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur. Click here to view press release. The post IntegraGen renews its agreement wit…

IntegraGen announces 2019 revenue of €8.3 million, up +20%, and cash position of €2.8 million as of December 31

IntegraGen announced today its unaudited business figures for the year 2019. 2019 revenue amounted to 8.3 M € versus 6.9 M € in 2018, an increase of 20% over 12 months. This performance highlights an acceleration from the high growth level of 15% reported for the first half of 2019. (…) (+) The pos…

IntegraGen announces 2019 first half results: Continued improvement in profitability

IntegraGen has announced today its financial results for the first half of 2019 with the accounts having been reviewed by the Board of Directors on 19 September 2019. Sales: 4.2 M€, up + 15% vs. H1 2018 Operating profit (EBITDA): -0.3 M€, up + 31% vs. H1 2018 (…) (+) The post IntegraGen announces …

Press release on General Assembly voting results

The mixed shareholders’ general meeting of IntegraGen was held on Thursday, June 13, 2019 at the Bedford Hotel’s premises at 17 rue de l’Arcade in Paris. At the end of the Combined General Meeting, (…) (+) The post Press release on General Assembly voting results appeared first on Integragen.
Show more

IntegraGen Frequently Asked Questions

  • When was IntegraGen founded?

    IntegraGen was founded in 2000.

  • Who are IntegraGen key executives?

    IntegraGen's key executives are Bernard Courtieu, Laurence Riot Lamotte and Bérengère Génin.

  • How many employees does IntegraGen have?

    IntegraGen has 42 employees.

  • Who are IntegraGen competitors?

    Competitors of IntegraGen include StemoniX, Ajinomoto Althea and Celcuity.

  • Where is IntegraGen headquarters?

    IntegraGen headquarters is located at 5 Rue Henri Auguste Desbruères, Évry.

  • Where are IntegraGen offices?

    IntegraGen has offices in Évry and Cambridge.

  • How many offices does IntegraGen have?

    IntegraGen has 2 offices.